A label-free detection assay is developed
based on the design and synthesis of a new anionic alkynylplatinum(II)
2,6-bis(benzimidazol-2′-yl)pyridine complex with water-soluble
pendants. With the aid of electrostatic interaction and noncovalent
metal–metal and π–π stacking interactions,
protamine is shown to induce supramolecular self-assembly of platinum(II)
complexes with drastic UV–vis absorption and red emission changes.
On the basis of the strong binding affinity of protamine and heparin,
the ensemble has been further employed to probe heparin by monitoring
the spectroscopic changes. Other than heparin, this ensemble can also
detect the activity of trypsin, which can hydrolyze protamine into
fragments, leading to the deaggregation of platinum(II) complexes.
By modulation of the self-assembly properties of platinum(II) complexes
via real-time UV–vis absorption and emission studies, the reported
assay has been demonstrated to be a sensitive and selective detection
method for trypsin, as well as trypsin inhibitor screening, which
is essential for drug discovery.